SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharmaceuticals submits newspaper advertisement

31 Dec 2018 Evaluate

Pursuant to Regulation 47 of SEBI (LODR), Jenburkt Pharmaceuticals has informed about submission of copies of newspaper advertisement regarding dispatch of Notice and Form of Postal Ballot and other details, as required. The Notice appeared in the Newspapers: The Free Press Journal, Mumbai - English and Navshakti, Mumbai -Marathi on Saturday, 29th December, 2018. The same has been uploaded on the website of the company, www.jenburkt.com.

The above information is a part of company’s filings submitted to BSE.

Jenburkt Pharma Share Price

1145.00 21.50 (1.91%)
05-Jun-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.95
Dr. Reddys Lab 1279.95
Cipla 1396.00
Zydus Lifesciences 1084.00
Lupin 2288.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×